Product image of Naratriptan Teva (Naratriptan) supplied by GNH India

Naratriptan Teva

Active Ingredient:
Naratriptan
Origin:
EU

Naratriptan Teva (Naratriptan)

Naratriptan, the active ingredient in Naratriptan Teva, is a Triptan (selective 5‑HT1B/1D receptor agonist) presented as an oral tablet. It is indicated for the acute treatment of migraine attacks in adult patients, providing relief from headache pain and associated symptoms such as nausea, photophobia, and phonophobia.

GNH India supplies Naratriptan Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand. All shipments are accompanied by full documentation for customs clearance.

Manufacturer / TM Owner

Teva B.V

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Naratriptan is used in the acute management of migraine, a disorder involving cranial blood vessel dilation and trigeminal nerve activation.

  • Migraine attack: provides rapid relief of headache pain and associated symptoms.
  • Migraine with aura: reduces severity of aura‑related discomfort when taken early.
  • Acute episodic migraine: helps abort attacks in patients with episodic migraine patterns.

How It Works

  • Naratriptan selectively binds to serotonin 5‑HT1B and 5‑HT1D receptors on intracranial blood vessels and trigeminal nerve endings. Activation of these receptors induces vasoconstriction of dilated cranial arteries and inhibits release of pro‑inflammatory neuropeptides, thereby interrupting the pain signaling cascade responsible for migraine attacks. The drug’s high affinity for these subtypes limits systemic cardiovascular effects while delivering targeted migraine relief significant.

Side Effects

Naratriptan may cause a range of adverse reactions, which are generally categorized by frequency and severity.

Common Side Effects

  • Dizziness: sensation of light‑headedness or unsteadiness.
  • Nausea: mild stomach upset or urge to vomit.
  • Dry mouth: reduced salivation leading to a parched feeling.
  • Fatigue: feeling unusually tired or weak.
  • Tingling: transient paresthesia in extremities.

Serious or Rare Side Effects

  • Chest discomfort: pressure or pain that may suggest cardiac involvement.
  • Serotonin syndrome: agitation, hyperthermia, and neuromuscular abnormalities when combined with other serotonergic agents.
  • Allergic reaction: rash, itching, swelling, or anaphylaxis.
  • Severe hypertension: sudden increase in blood pressure.
  • Ischemic events: rare cases of stroke or myocardial infarction.

Precautions & Warnings

When prescribing Naratriptan, clinicians should consider several precautionary measures to ensure safe use.

  • Cardiovascular assessment: avoid use in patients with uncontrolled hypertension or coronary artery disease.
  • Medication history: review for concurrent serotonergic drugs to reduce risk of serotonin syndrome.
  • Age considerations: use with caution in elderly patients due to increased sensitivity to side effects.
  • Pregnancy and lactation: assess risk–benefit, as safety data are limited.
  • Driving and machinery: advise patients that dizziness may impair ability to operate vehicles.
  • Store at ambient temperature: keep tablets below 25 °C in the original container, protected from moisture.

Avoid Interactions

Naratriptan can interact with other medicines, altering its efficacy or increasing adverse effect risk.

Major Interactions (Avoid)

  • MAO inhibitors: concurrent use may precipitate severe hypertension.
  • Ergot alkaloids: combined vasoconstriction can lead to coronary spasm.
  • SSRIs/SNRIs: increased risk of serotonin syndrome.

Moderate Interactions (Monitor Closely)

  • Beta‑blockers: may enhance antihypertensive effect, requiring blood pressure monitoring.
  • CYP1A2 inhibitors (e.g., fluvoxamine): can raise naratriptan plasma levels.
  • Antihypertensive agents: monitor for additive blood pressure lowering.

Frequently Asked Questions

Naratriptan Teva is prescribed for the acute treatment of migraine attacks in adults. It helps relieve headache pain and associated symptoms such as nausea, sensitivity to light, and sound when taken at the onset of an attack.

Naratriptan works by selectively activating serotonin 5‑HT1B and 5‑HT1D receptors on cranial blood vessels and trigeminal nerve endings. This activation causes vasoconstriction of dilated vessels and blocks the release of inflammatory neuropeptides, interrupting the migraine pain pathway.

The dosage of Naratriptan Teva is determined by the prescribing healthcare professional based on the patient’s clinical condition, response, and any concomitant therapies. Patients should follow the prescriber’s instructions and not alter the dose without medical advice.

Safety data for Naratriptan in pregnancy and lactation are limited. Clinicians should weigh the potential benefits against possible risks and consider alternative therapies when appropriate. Women who are pregnant, planning pregnancy, or breastfeeding should discuss treatment options with their healthcare provider.

To order Naratriptan Teva, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Naratriptan belongs to the Triptan class, similar to sumatriptan and rizatriptan. Compared with some alternatives, Naratriptan has a longer half‑life, which may provide extended relief for prolonged attacks, while its side‑effect profile is generally comparable. Choice of therapy depends on individual response, tolerability and physician judgment.

Naratriptan tablets should be stored at ambient temperature, below 25 °C, in the original packaging to protect them from moisture and light. Keep the product out of reach of children and do not use if the packaging is damaged.

Naratriptan is taken orally as a tablet. The tablet should be swallowed whole with a glass of water, preferably as soon as migraine symptoms begin. Patients should not crush, chew, or split the tablet unless specifically instructed by a healthcare professional.

Serious risks include chest discomfort or pain that may indicate cardiac involvement, severe hypertension, serotonin syndrome when combined with other serotonergic agents, and rare allergic reactions such as anaphylaxis. Patients experiencing any of these symptoms should seek immediate medical attention.

Naratriptan is contraindicated in patients with uncontrolled hypertension, known coronary artery disease, a history of myocardial infarction or stroke, and those currently taking MAO inhibitors or ergot alkaloids. It should also be avoided in individuals with known hypersensitivity to naratriptan or any of its excipients.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Naratriptan

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT